NSE · AI Signal & Stock Analysis · Bearish
As of Sep 9 2026, 6:14 AM, AkshayaAI's signal for NOVARTIND is Bearish ↓ (moderate move); technical trend raise-2026-08-31; trading at ₹1,639.60 (-0.43% today); neutral (RSI 61).
Data as of Sep 9 2026, 6:14 AM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | RAISE-2026-08-31 |
| Price | ₹1,639.60 |
| Change today | -0.43% |
| RSI (14) | 60.90 |
| Relative volume | 2.26 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹5,398 Cr |
| P/E | 49.59 |
| Cap category | Mid Cap |
| 52-week high | -3.7% away |
| 52-week low | +191.9% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 9 2026, 6:14 AM, AkshayaAI's signal for NOVARTIND (Novartis India Limited) is Bearish with a moderate move, and its technical trend is raise-2026-08-31. The composite score and full factor breakdown are available to signed-in members.
NOVARTIND's RSI is neutral (RSI 61). A reading above 70 is typically overbought and below 30 oversold.
NOVARTIND is trading about 4% below its 52-week high and 192% above its 52-week low as of Sep 9 2026, 6:14 AM.
NOVARTIND's market capitalisation is ₹5,398 Cr as of Sep 9 2026, 6:14 AM.
NOVARTIND is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for NOVARTIND — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 9 2026, 6:14 AM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.